The use of PPIs prior to endoscopy is recommended for all patients because it significantly reduces the severity of bleeding and the necessity of endoscopic therapy. Even so, it only reduces the risk of rebleeding modestly, and it does not reduce the risk of mortality 34,35.
La utilización de IBPs pre-endoscopia se recomienda para todos los pacientes, ya que reduce de manera significativa la severidad del sangrado y la necesidad de terapia endoscópica, aunque solo reduce modestamente el riesgo de resangrado y no modifica la mortalidad 34, 35.